Codes / ICD10CM / M05.21

M05.21 Rheumatoid vasculitis with rheumatoid arthritis of shoulder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid vasculitis with rheumatoid arthritis of shoulder

Summary

Rheumatoid vasculitis with rheumatoid arthritis of shoulder is a localized complication of rheumatoid arthritis (RA) involving inflammation of blood vessels in the shoulder region. It occurs when the systemic immune dysregulation of RA affects vascular structures, potentially leading to tissue damage or functional impairment in the shoulder area. This condition reflects the localized impact of RA’s inflammatory processes on specific anatomical sites.

Causes

The exact cause of rheumatoid vasculitis is not fully understood. It is believed to result from chronic inflammation and immune dysregulation associated with rheumatoid arthritis, leading to vascular damage. Autoantibodies, immune complexes, and inflammatory cytokines may contribute to vessel inflammation, though the precise mechanisms remain under investigation.

Risk Factors

  • Long-standing, severe rheumatoid arthritis
  • High disease activity or titers of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA)
  • Presence of subcutaneous nodules
  • Male gender
  • Older age

Symptoms

  • Shoulder pain, stiffness, or swelling
  • Skin manifestations (e.g., purpura, ulcers, or nodules) in the shoulder area
  • Peripheral neuropathy affecting the shoulder or arm
  • Systemic symptoms (e.g., fever, weight loss, fatigue)
  • Reduced range of motion or functional impairment in the shoulder

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., MRI or ultrasound of the shoulder), and laboratory tests to assess inflammatory markers and autoantibodies. Biopsy of affected tissue may be performed to confirm vasculitis. Documentation should specify the shoulder as the site of involvement.

Treatment Options

  • Disease-modifying antirheumatic drugs (DMARDs) to control underlying RA
  • Corticosteroids to reduce inflammation
  • Immunosuppressive agents for severe cases
  • Physical therapy to maintain shoulder function
  • Symptomatic management (e.g., pain relief, wound care for skin lesions)

Prognosis and Follow-Up

Prognosis depends on the severity of vasculitis and response to treatment. Early intervention improves outcomes, but recurrent inflammation or organ involvement may occur. Regular follow-up with rheumatology and orthopedic specialists is recommended to monitor disease activity and adjust therapy.

Complications

  • Chronic shoulder pain or disability
  • Skin ulceration or necrosis
  • Nerve damage leading to weakness or sensory loss
  • Systemic spread of vasculitis affecting other organs

Lifestyle & Prevention

  • Adherence to RA treatment regimens to control disease activity
  • Regular exercise to maintain shoulder mobility
  • Avoidance of smoking, which exacerbates RA and vasculitis risk
  • Prompt reporting of new or worsening symptoms to healthcare providers

When to Seek Professional Help

Seek immediate medical attention for:

  • Sudden severe shoulder pain or swelling
  • Skin changes (e.g., ulcers, discoloration)
  • Neurological symptoms (e.g., numbness, weakness)
  • Signs of infection (e.g., fever, redness)

Tips for Medical Coders

Document the shoulder as the site of rheumatoid vasculitis involvement to support code assignment. Ensure clinical documentation specifies both the vasculitis and the underlying rheumatoid arthritis of the shoulder. Review medical records for confirmation of site-specific manifestations and exclude other causes of shoulder inflammation.

Book a walkthrough

M05.21 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.